scispace - formally typeset
C

Camila Ragne Torreglosa

Researcher at University of São Paulo

Publications -  18
Citations -  506

Camila Ragne Torreglosa is an academic researcher from University of São Paulo. The author has contributed to research in topics: Randomized controlled trial & Internal medicine. The author has an hindex of 8, co-authored 16 publications receiving 312 citations.

Papers
More filters
Journal ArticleDOI

Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care

TL;DR: The TyG index was positively associated with a higher prevalence of symptomatic CAD, with metabolic and behavioral risk factors, and could be used as a marker for atherosclerosis.
Journal ArticleDOI

Effects of oral supplementation with probiotics or synbiotics in overweight and obese adults: a systematic review and meta-analyses of randomized trials

TL;DR: The findings suggest that oral supplementation with probiotics or synbiotics has a small effect to reduce waist circumference but no effect on body weight or BMI, although the quality of evidence is low to moderate.
Journal ArticleDOI

Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study.

TL;DR: Subjects in secondary prevention for cardiovascular disease with insulin resistance have a higher concentration of hs-CRP and IL-6 than individuals without insulin resistance, and these inflammatory biomarkers are positively associated with saturated fatty acids and negatively associated with unsaturated fatty acids.
Journal ArticleDOI

The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)

Bernardete Weber, +231 more
TL;DR: If the BALANCE Program is found to decrease cardiovascular events and reduce risk factors, this may represent an advance in the care of patients with cardiovascular disease.